Literature DB >> 1847719

Tumor necrosis factor-alpha is chemokinetic for lymphokine-activated killer cells: regulation by cyclic adenosine monophosphate.

A A Maghazachi1.   

Abstract

The ability of tumor necrosis factor-alpha (TNF-alpha) to attract lymphokine-activated killer (LAK) cells in vitro was examined. Utilizing modified Boyden chambers (BC), it was observed that TNF-alpha is not chemoattractant for LAK cells. On the other hand, TNF-alpha attracted both fresh and concanavalin A-activated T cells. However, when TNF-alpha was incubated in the upper compartments of BC and in the presence of LAK cells, it enhanced the random movement of these cells across the polycarbonate membranes. The effect of TNF-alpha was inhibited by incorporating anti-TNF-alpha antibody, or a high concentration (10 ng) of TFG-beta 1. The activity of TGF-beta 1 was reversed by anti-TGF-beta 1 antibody. Cholera toxin (CT), which is known to activate the endogenous level of cyclic adenosine monophosphate (cAMP) also inhibited TNF-alpha-induced LAK cell chemokinesis. The effect of CT was mimicked by the cAMP analog dibutyryl cAMP or by the phosphodiesterase inhibitors isobutyl methylxanthine or aminophylline. Measurement of the intracellular level of cAMP showed that cells incubated for 1, 2, or 4 hr with TNF-alpha have a lower level of cAMP, whereas those incubated with a high concentration of TGF-beta 1 produced significantly higher levels of this messenger. cAMP level was also increased in cells incubated with TGF-beta 1 plus TNF-alpha. This level was reduced to the background when anti-TGF-beta 1 antibody was added to the cultures. These results suggest that cAMP negatively regulates LAK cell chemokinesis.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1847719     DOI: 10.1002/jlb.49.3.302

Source DB:  PubMed          Journal:  J Leukoc Biol        ISSN: 0741-5400            Impact factor:   4.962


  7 in total

1.  Tumour necrosis factor-alpha stimulates invasiveness of T-cell hybridomas and cytotoxic T-cell clones by a pertussis toxin-insensitive mechanism.

Authors:  G La Rivière; J W Klein Gebbinck; C A Schipper; E Roos
Journal:  Immunology       Date:  1992-02       Impact factor: 7.397

2.  Rat macrophage activation after treatment with the bleomycin group of antitumour antibiotics in vivo.

Authors:  M Micallef; M Hosokawa; Y Togashi; H Kobayashi
Journal:  Cancer Immunol Immunother       Date:  1992       Impact factor: 6.968

3.  Cholera toxin inhibits interleukin-2-induced, but enhances pertussis toxin-induced T-cell proliferation: regulation by cyclic nucleotides.

Authors:  A A Maghazachi
Journal:  Immunology       Date:  1992-01       Impact factor: 7.397

Review 4.  Toxins-useful biochemical tools for leukocyte research.

Authors:  Susana Cubillos; Johannes Norgauer; Katja Lehmann
Journal:  Toxins (Basel)       Date:  2010-03-26       Impact factor: 4.546

5.  Recruitment and activation of natural killer (NK) cells in vivo determined by the target cell phenotype. An adaptive component of NK cell-mediated responses.

Authors:  R Glas; L Franksson; C Une; M L Eloranta; C Ohlén; A Orn; K Kärre
Journal:  J Exp Med       Date:  2000-01-03       Impact factor: 14.307

Review 6.  Phosphodiesterase 4B: Master Regulator of Brain Signaling.

Authors:  Amy J Tibbo; George S Baillie
Journal:  Cells       Date:  2020-05-19       Impact factor: 6.600

7.  An essential role for tumor necrosis factor in natural killer cell-mediated tumor rejection in the peritoneum.

Authors:  M J Smyth; J M Kelly; A G Baxter; H Körner; J D Sedgwick
Journal:  J Exp Med       Date:  1998-11-02       Impact factor: 14.307

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.